CEREBROSPINAL FLUID BIOPTERIN AND BIOGENIC AMINE METABOLITES DURING ORAL R-THBP THERAPY FOR INFANTILE AUTISM
محفوظ في:
KOMORI, H., ET AL., CEREBROSPINAL FLUID BIOPTERIN AND BIOGENIC AMINE METABOLITES DURING ORAL R-THBP THERAPY FOR INFANTILE AUTISM. JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, Vol. 25, no. 2 (1995), p. 183-193.
Ref.
48915
الموقع:
SIIS R.237
Palabras clave:
Autismo, Conducta, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista
Autismo, Conducta, Discapacidad, Discapacidad del lenguaje, Discapacidad intelectual, Fármacos, Trastornos del espectro autista
مواد مشابهة: CEREBROSPINAL FLUID BIOPTERIN AND BIOGENIC AMINE METABOLITES DURING ORAL R-THBP THERAPY FOR INFANTILE AUTISM
- URINARY LEVELS OF BIOGENIC AMINE METABOLITES IN MENTALLY RETARDED CHILDREN
- CEREBROSPINAL FLUID NUCLEOTIDE METABOLITES FOLLOWING SHORT FEBRILE CONVULSIONS
- CEREBROSPINAL FLUID NUCLEOTIDE METABOLITES FOLLOWING NON-CONVULSIVE STATUS EPILEPTICUS
- CEREBROSPINAL FLUID INDOLEACETIC ACID IN AUTISTIC SUBJECTS
- GANGLIOSIDES IN CEREBROSPINAL FLUID IN CHILDREN WITH AUTISM SPECTRUM DISORDERS
- LEVELS OF CEREBROSPINAL FLUID NERVE-GROWTH FACTOR DIFFER IN INFANTILE AUTISM AND RETT SYNDROME